Trials / Active Not Recruiting
Active Not RecruitingNCT06707688
Abbott Medical - VERITAS Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 458 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the safety and effectiveness of Abbott's Amulet™ 2 Left Atrial Appendage (LAA) occluder device (Amulet 2 device) in patients who have non-valvular atrial fibrillation and who are at increased risk for stroke and systemic embolism and have appropriate rationale to seek a non-pharmacologic alternative to oral anticoagulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Amulet™ 2 Left Atrial Appendage (LAA) Occluder | Patient will undergo the implantation of the Amulet™ 2 Left Atrial Appendage (LAA) Occluder |
Timeline
- Start date
- 2024-11-07
- Primary completion
- 2025-11-06
- Completion
- 2027-09-01
- First posted
- 2024-11-27
- Last updated
- 2026-02-18
Locations
35 sites across 9 countries: United States, Belgium, Canada, Denmark, France, Germany, Italy, Spain, Switzerland
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06707688. Inclusion in this directory is not an endorsement.